7th Treg-Directed Therapies Summit Revere Hotel Boston Common, Boston
Over the past year, the Treg sector has seen groundbreaking investments and strategic collaborations between leading biotech and pharma companies like Quell and AstraZeneca, and Parvus and AbbVie, creating a surge of innovation and spotlighting Treg cell therapies and modulators as the next frontier in autoimmune and inflammatory disease treatments. Tregs hold the potential to revolutionize care for conditions that have long lacked effective solutions and are the future of precision medicine in autoimmune and inflammatory diseases.
⌛ Event Dates & Venue
💸 Website & Tickets
Go to Event WebsiteDrug Developer Pricing - Conference + Treg Biology Focus Day: USD 4197.00, Drug Developer Pricing - Conference Only: USD 2999.00, Academic and Start-Up Pricing - Conference + Treg Biology Focus Day: USD 3597.00, Academic and Start-Up Pricing - Conference Only: USD 2599.00, Solution and Service Provider Pricing - Conference + Treg Biology Focus Day: USD 5097.00, Solution and Service Provider Pricing - Conference Only: USD 3699.00
Advertisements